These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

474 related articles for article (PubMed ID: 23108115)

  • 1. Pharmacological inhibition of adipocyte fatty acid binding protein alleviates both acute liver injury and non-alcoholic steatohepatitis in mice.
    Hoo RL; Lee IP; Zhou M; Wong JY; Hui X; Xu A; Lam KS
    J Hepatol; 2013 Feb; 58(2):358-64. PubMed ID: 23108115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peroxisome proliferator-activated receptor-α agonist, Wy 14,643, improves metabolic indices, steatosis and ballooning in diabetic mice with non-alcoholic steatohepatitis.
    Larter CZ; Yeh MM; Van Rooyen DM; Brooling J; Ghatora K; Farrell GC
    J Gastroenterol Hepatol; 2012 Feb; 27(2):341-50. PubMed ID: 21929649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toll-like receptor-4 mediates obesity-induced non-alcoholic steatohepatitis through activation of X-box binding protein-1 in mice.
    Ye D; Li FY; Lam KS; Li H; Jia W; Wang Y; Man K; Lo CM; Li X; Xu A
    Gut; 2012 Jul; 61(7):1058-67. PubMed ID: 22253482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection against Western diet-induced obesity and hepatic steatosis in liver fatty acid-binding protein knockout mice.
    Newberry EP; Xie Y; Kennedy SM; Luo J; Davidson NO
    Hepatology; 2006 Nov; 44(5):1191-205. PubMed ID: 17058218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mAb against adipocyte fatty acid-binding protein 2E4 attenuates the inflammation in the mouse model of high-fat diet-induced obesity via toll-like receptor 4 pathway.
    Miao X; Wang Y; Wang W; Lv X; Wang M; Yin H
    Mol Cell Endocrinol; 2015 Mar; 403():1-9. PubMed ID: 25596549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxic lipids stored by Kupffer cells correlates with their pro-inflammatory phenotype at an early stage of steatohepatitis.
    Leroux A; Ferrere G; Godie V; Cailleux F; Renoud ML; Gaudin F; Naveau S; Prévot S; Makhzami S; Perlemuter G; Cassard-Doulcier AM
    J Hepatol; 2012 Jul; 57(1):141-9. PubMed ID: 22425624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutralization of interleukin-17 attenuates high fat diet-induced non-alcoholic fatty liver disease in mice.
    Xu R; Tao A; Zhang S; Zhang M
    Acta Biochim Biophys Sin (Shanghai); 2013 Sep; 45(9):726-33. PubMed ID: 23786840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Celecoxib attenuates liver steatosis and inflammation in non-alcoholic steatohepatitis induced by high-fat diet in rats.
    Chen J; Liu D; Bai Q; Song J; Guan J; Gao J; Liu B; Ma X; Du Y
    Mol Med Rep; 2011; 4(5):811-6. PubMed ID: 21643627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined effects of rosiglitazone and conjugated linoleic acid on adiposity, insulin sensitivity, and hepatic steatosis in high-fat-fed mice.
    Liu LF; Purushotham A; Wendel AA; Belury MA
    Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1671-82. PubMed ID: 17322064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ezetimibe improves high fat and cholesterol diet-induced non-alcoholic fatty liver disease in mice.
    Zheng S; Hoos L; Cook J; Tetzloff G; Davis H; van Heek M; Hwa JJ
    Eur J Pharmacol; 2008 Apr; 584(1):118-24. PubMed ID: 18329014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kupffer cell activation is a causal factor for hepatic insulin resistance.
    Lanthier N; Molendi-Coste O; Horsmans Y; van Rooijen N; Cani PD; Leclercq IA
    Am J Physiol Gastrointest Liver Physiol; 2010 Jan; 298(1):G107-16. PubMed ID: 19875703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Possible involvement and the mechanisms of excess trans-fatty acid consumption in severe NAFLD in mice.
    Obara N; Fukushima K; Ueno Y; Wakui Y; Kimura O; Tamai K; Kakazu E; Inoue J; Kondo Y; Ogawa N; Sato K; Tsuduki T; Ishida K; Shimosegawa T
    J Hepatol; 2010 Aug; 53(2):326-34. PubMed ID: 20462650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FXR agonist GW4064 alleviates endotoxin-induced hepatic inflammation by repressing macrophage activation.
    Yao J; Zhou CS; Ma X; Fu BQ; Tao LS; Chen M; Xu YP
    World J Gastroenterol; 2014 Oct; 20(39):14430-41. PubMed ID: 25339829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear factor high-mobility group box1 mediating the activation of Toll-like receptor 4 signaling in hepatocytes in the early stage of nonalcoholic fatty liver disease in mice.
    Li L; Chen L; Hu L; Liu Y; Sun HY; Tang J; Hou YJ; Chang YX; Tu QQ; Feng GS; Shen F; Wu MC; Wang HY
    Hepatology; 2011 Nov; 54(5):1620-30. PubMed ID: 21809356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha-lipoic acid attenuates methionine choline deficient diet-induced steatohepatitis in C57BL/6 mice.
    Min AK; Kim MK; Kim HS; Seo HY; Lee KU; Kim JG; Park KG; Lee IK
    Life Sci; 2012 Jan; 90(5-6):200-5. PubMed ID: 22154902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dietary advanced glycation end-products aggravate non-alcoholic fatty liver disease.
    Leung C; Herath CB; Jia Z; Andrikopoulos S; Brown BE; Davies MJ; Rivera LR; Furness JB; Forbes JM; Angus PW
    World J Gastroenterol; 2016 Sep; 22(35):8026-40. PubMed ID: 27672297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roles of adipose restriction and metabolic factors in progression of steatosis to steatohepatitis in obese, diabetic mice.
    Larter CZ; Yeh MM; Van Rooyen DM; Teoh NC; Brooling J; Hou JY; Williams J; Clyne M; Nolan CJ; Farrell GC
    J Gastroenterol Hepatol; 2009 Oct; 24(10):1658-68. PubMed ID: 19788606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrahepatic cholesterol influences progression, inhibition and reversal of non-alcoholic steatohepatitis in hyperlipidemic mice.
    Wouters K; van Bilsen M; van Gorp PJ; Bieghs V; Lütjohann D; Kerksiek A; Staels B; Hofker MH; Shiri-Sverdlov R
    FEBS Lett; 2010 Mar; 584(5):1001-5. PubMed ID: 20114046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycine attenuates endotoxin-induced liver injury by downregulating TLR4 signaling in Kupffer cells.
    Xu FL; You HB; Li XH; Chen XF; Liu ZJ; Gong JP
    Am J Surg; 2008 Jul; 196(1):139-48. PubMed ID: 18565339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CXC chemokine receptor 3 promotes steatohepatitis in mice through mediating inflammatory cytokines, macrophages and autophagy.
    Zhang X; Han J; Man K; Li X; Du J; Chu ES; Go MY; Sung JJ; Yu J
    J Hepatol; 2016 Jan; 64(1):160-70. PubMed ID: 26394162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.